FDA Approvals in Oncology: October-December 2023
In the final quarter of 2023, the FDA issued 17 approvals specifically for the treatment of tumors.
Category: FDA Approvals
In the final quarter of 2023, the FDA issued 17 approvals specifically for the treatment of tumors.
The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of...
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...